Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alon Ben Nun

Showing results (31-40 of 45) with videos related to

Pageof 5
Sort By:
Clinical Lung Cancer|December 28, 2013
Genetic mutation screen in early non--small-cell lung cancer (NSCLC) specimensJair Bar, Maya Damianovich, Goni Hout Siloni, et al.
Experimental and Therapeutic Medicine|September 13, 2012
Adoptive cell therapy with autologous tumor-infiltrating lymphocytes and high-dose interleukin-2 for metastatic melanoma: The surgeon's perspectiveDouglas B Zippel, Michal Besser, Roni Shapira, et al.
Molecular Cancer Research : MCR|March 15, 2020
Stromal-MDM2 Promotes Lung Cancer Cell Invasion through Tumor-Host Feedback SignalingIris Kamer, Inbal Daniel-Meshulam, Oranit Zadok, et al.
Cancer Immunology, Immunotherapy : CII|January 23, 2021
Immunotherapy response modeling by ex-vivo organ culture for lung cancerIris Kamer, Elizabeta Bab-Dinitz, Oranit Zadok, et al.
Translational Lung Cancer Research|July 18, 2020
Predicting brain metastasis in early stage non-small cell lung cancer patients by gene expression profilingIris Kamer, Yael Steuerman, Inbal Daniel-Meshulam, et al.
The Israel Medical Association Journal : IMAJ|May 1, 2017
Stereotactic Ablative Body Radiation for Stage I Lung Cancer in Israel: A Retrospective Single-Center ReportSarit Appel, Yaacov R Lawrence, Jeffery Goldstein, et al.
Cancer Investigation|September 4, 2023
Tumor Differentiation as a Prognostic Marker in Clinically Staged T1bN0 Esophageal AdenocarcinomaOfer Margalit, Einat Shacham-Shmueli, Gal Strauss, et al.
The Israel Medical Association Journal : IMAJ|November 6, 2017
Neo-adjuvant Chemo-Radiation to 60 Gray Followed by Surgery for Locally Advanced Non-Small Cell Lung Cancer Patients: Evaluation of Trimodality StrategySarit Appel, Jeffry Goldstein, Marina Perelman, et al.
The British Journal of Radiology|September 26, 2023
Effects of EGFR driver mutations on pathologic regression in resectable locally advanced non-small cell lung cancer treated with neoadjuvant chemoradiation and completion surgerySarit Appel, Jair Bar, Akram Saad, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|April 4, 2009
Minimally cultured or selected autologous tumor-infiltrating lymphocytes after a lympho-depleting chemotherapy regimen in metastatic melanoma patientsMichal J Besser, Ronnie Shapira-Frommer, Avraham J Treves, et al.
Pageof 5

Showing results (31-40 of 45) with videos related to

Sort By:
Pageof 5
Clinical Lung Cancer|December 28, 2013
Genetic mutation screen in early non--small-cell lung cancer (NSCLC) specimensJair Bar, Maya Damianovich, Goni Hout Siloni, et al.
Experimental and Therapeutic Medicine|September 13, 2012
Adoptive cell therapy with autologous tumor-infiltrating lymphocytes and high-dose interleukin-2 for metastatic melanoma: The surgeon's perspectiveDouglas B Zippel, Michal Besser, Roni Shapira, et al.
Molecular Cancer Research : MCR|March 15, 2020
Stromal-MDM2 Promotes Lung Cancer Cell Invasion through Tumor-Host Feedback SignalingIris Kamer, Inbal Daniel-Meshulam, Oranit Zadok, et al.
Cancer Immunology, Immunotherapy : CII|January 23, 2021
Immunotherapy response modeling by ex-vivo organ culture for lung cancerIris Kamer, Elizabeta Bab-Dinitz, Oranit Zadok, et al.
Translational Lung Cancer Research|July 18, 2020
Predicting brain metastasis in early stage non-small cell lung cancer patients by gene expression profilingIris Kamer, Yael Steuerman, Inbal Daniel-Meshulam, et al.
The Israel Medical Association Journal : IMAJ|May 1, 2017
Stereotactic Ablative Body Radiation for Stage I Lung Cancer in Israel: A Retrospective Single-Center ReportSarit Appel, Yaacov R Lawrence, Jeffery Goldstein, et al.
Cancer Investigation|September 4, 2023
Tumor Differentiation as a Prognostic Marker in Clinically Staged T1bN0 Esophageal AdenocarcinomaOfer Margalit, Einat Shacham-Shmueli, Gal Strauss, et al.
The Israel Medical Association Journal : IMAJ|November 6, 2017
Neo-adjuvant Chemo-Radiation to 60 Gray Followed by Surgery for Locally Advanced Non-Small Cell Lung Cancer Patients: Evaluation of Trimodality StrategySarit Appel, Jeffry Goldstein, Marina Perelman, et al.
The British Journal of Radiology|September 26, 2023
Effects of EGFR driver mutations on pathologic regression in resectable locally advanced non-small cell lung cancer treated with neoadjuvant chemoradiation and completion surgerySarit Appel, Jair Bar, Akram Saad, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|April 4, 2009
Minimally cultured or selected autologous tumor-infiltrating lymphocytes after a lympho-depleting chemotherapy regimen in metastatic melanoma patientsMichal J Besser, Ronnie Shapira-Frommer, Avraham J Treves, et al.
Pageof 5